1. Catheter Insertion and Vascular Access
The femoral artery (or occasionally the brachial or radial artery) provides access. Fluoroscopic guidance is used to progress a guiding catheter through the arterial system.

The femoral artery (or occasionally the brachial or radial artery) provides access. Fluoroscopic guidance is used to progress a guiding catheter through the arterial system.
A microcatheter is placed right at or very close to the thrombus in the blocked artery after being carefully inserted into the cerebral circulation through the major arteries.
Injection of contrast dye verifies the microcatheter's location and gives a clear picture of the vessel's structure and the size of the clot.
To locally break the clot, a concentrated bolus or gradual continuous infusion of a thrombolytic drug (such as urokinase or alteplase) is injected directly into the thrombus via a microcatheter.
Angiograms are performed on a regular basis to evaluate clot lysis. The microcatheter may be moved to maximize delivery based on the patient's progress, or multiple boluses may be given if necessary.
In order to maximize effectiveness and reduce bleeding risk, the infusion usually lasts several hours (often longer than 12–24 hours), with careful dose and infusion rate adjustments.
Adjunctive methods such as balloon angioplasty, stenting, or low-dose heparin infusion may be used if needed to maximize vascular patency.
All catheters are removed once recanalization is adequate. The patient's neurological condition and any potential problems, including bleeding or distal embolization, are continuously monitored.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Related Acute Ischemic Stroke: especially in the proximal middle cerebral artery, distal carotid, or basilar artery when IV thrombolysis is not recommended or is ineffective.
Patients who present outside of the 4.5-hour window for IV tPA but within 6 hours of the beginning of symptoms, or up to 24 hours in certain circumstances based on imaging, are considered to be beyond the standard IV thrombolysis time window.
Individuals who are contraindicated for IV thrombolysis include those who have coagulopathy or an increased INR, which increases the danger of systemic thrombolytics.
In order to manage distant emboli, improve recanalization, or get past chronic blockage, IAT may be employed in addition to thrombectomy.
They showed little core infarct and a salvageable penumbra on MRI or perfusion imaging.
Patients under 68 years old, those with NIHSS scores between 11 and 20, and those with lower infarct volumes had better outcomes.
Compared to systemic IV thrombolysis alone, IAT can improve the reopening of blocked big arteries by delivering thrombolytic drugs directly to the clot.
IAT in conjunction with mechanical thrombectomy has been linked to increased rates of functional independence at 90 days in a subset of patients with major artery occlusions.
IAT may improve microvascular perfusion and lessen the no-reflow problem by dissolving microthrombi that mechanical devices cannot reach.
Helpful when thrombectomy is insufficient if systemic lytics are unable to completely destroy the clot.
Under the guidance of sophisticated imaging, IAT can be used after the typical 4.5-hour limit for systemic thrombolysis.
When IAT is combined with mechanical thrombectomy, some research indicates a lower 90-day mortality rate without an increase in symptomatic cerebral bleeding.







